ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 020

Murine Roseolovirus Induces Autoimmune Disease and Development of Autoantibodies

Tarin Bigley1 and Wayne Yokoyama 2, 1Washington University in St. Louis, Saint Louis, Missouri, 2Washington University in St. Louis, St Louis, Missouri

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Auto-immunity, autoantibodies, immune tolerance, viruses

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Title: Poster Breakout 2 – Genetics & Pathogenesis

Session Type: Poster Breakout Session

Session Time: 5:10PM-5:40PM

Background/Purpose: Murine roseolovirus (MRV) is a recently sequenced beta-herpesvirus that is a natural murine pathogen and is genetically highly related to HHV6 and HHV7. The human roseoloviruses, HHV6 and HHV7, have been associated with autoimmune disease. Demonstrating causality has been difficult due to the ubiquitous and chronic nature of roseolovirus infections. Herein we have demonstrated that neonatal MRV infection induces autoimmune disease and development of autoantibodies in adult mice.

Methods: To evaluate the role of MRV in autoimmune disease, mice were infected within the first 48 hours of life. At 12 weeks post infection (wpi) we performed autoantibody screening as well as histology to identify organ specific tissue inflammation. We utilized flow cytometry and immunofluorescence to characterize the immune response, both systemically and within tissues. Antiviral treatment with ganciclovir was utilized to inhibit viral replication.

Results: Our studies show that autoimmune gastritis occurs in the absence of detectable virus in the gastric mucosa. Neonatal MRV infection results in a transient reduction in thymic and peripheral CD4+Foxp3+ regulatory T cells (Treg). Ganciclovir (GCV), a potent inhibitor of replication of other beta-herpesviruses, inhibits MRV replication as well as MRV-mediated CD4+ T cell and Treg depletion. Treatment with GCV early in life also reduces autoimmune gastritis, suggesting that MRV replication is necessary for altering immunologic tolerance early in life. The inflammatory infiltrate in the gastric mucosa is characterized by an increase in T cells, neutrophils and eosinophils. Furthermore, the CD4+ T cells in the gastric mucosa express IL-17 and IL-4, demonstrating a Th2 and Th17 response. The development of autoimmune gastritis was found to be T cell dependent. Interestingly, neonatal MRV infection results in the production of a wide array of autoantibodies in adult mice, including those associated with rheumatologic disease such as dsDNA, Scl-70, SSA, SSB, Jo-1, Smith, GBM and MPO.

Conclusion: This study shows that neonatal infection with MRV results in the development of autoimmunity later in life, after acute infection has been cleared. Taken together, these findings strongly suggest that infection with a roseolovirus infection early in life results in disruption of immunologic tolerance and development of autoimmune disease.


Disclosure: T. Bigley, None; W. Yokoyama, None.

To cite this abstract in AMA style:

Bigley T, Yokoyama W. Murine Roseolovirus Induces Autoimmune Disease and Development of Autoantibodies [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/murine-roseolovirus-induces-autoimmune-disease-and-development-of-autoantibodies/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/murine-roseolovirus-induces-autoimmune-disease-and-development-of-autoantibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology